Old Web
English
Sign In
Acemap
>
authorDetail
>
J. L. Cunneen
J. L. Cunneen
Oncology
Toxicity
Internal medicine
Medicine
Relapsed Small Cell Lung Cancer
3
Papers
13
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Pemetrexed (P) in relapsed small cell lung cancer (SCLC): Preliminary results of a phase II trial
2007
Journal of Clinical Oncology
R. N. Raju
Marcus A. Neubauer
David Smith
Donald A. Richards
Lina Asmar
J. L. Cunneen
Ruqin Chen
D. F. Tai
Coleman K. Obasaju
M. A. Socinski
Show All
Source
Cite
Save
Citations (6)
A randomized phase 3 trial of gemcitabine with or without carboplatin in performance status 2 (PS2) patients (pts) with advanced (stage IIIB with pleural effusion or stage IV) non-small cell lung cancer (NSCLC)
2007
Journal of Clinical Oncology
Coleman K. Obasaju
Paul Conkling
Donald A. Richards
James F. Fitzgibbons
J. Arceneau
Kristi A. Boehm
Lina Asmar
J. L. Cunneen
Guangbin Peng
Craig H. Reynolds
Show All
Source
Cite
Save
Citations (6)
The impact of shortened vitamin supplementation lead-in time before pemetrexed (P) in patients with relapsed small cell lung cancer (SCLC)
2007
Journal of Clinical Oncology
Donald A. Richards
M. A. Socinski
Robert N. Raju
K. Coke
Craig H. Reynolds
Ruqin Chen
J. L. Cunneen
D. F. Tai
Joseph Treat
Coleman K. Obasaju
Show All
Source
Cite
Save
Citations (1)
1